Medical researchers applied CRISPR technology to study the function of a very large human non-protein coding gene expressed only in placenta, stem cells, and certain cancers
Japanese researchers led by Osaka University show that a Class 1 CRISPR gene editing system can achieve functional DNA repairs in human cells with no prominent off-target effects